The heart and the waist: Relationship between abdominal fat and recurrent events after myocardial infarction

Abstract

Get full access to this article

View all access options for this article.

References

Fan

Song

Chen

, et al. Combined effect of obesity and cardiometabolic abnormality on the risk of cardiovascular disease: A meta-analysis of prospective cohort studies. Int J Cardiol 2013; 168: 4761–4768.

Matsuzawa

Lerman

. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 2014; 25: 713–724.

Piepoli

Hoes

Agewall

, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.

Cavallari

Cannon

Braunwald

, et al. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. Eur J Prev Cardiol 2018; 25: 830–838.

Romero-Corral

Montori

Somers

, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet 2006; 368: 666–678.

Fox

Massaro

Hoffmann

, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39–48.

Despres

Lemieux

. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

Hansel

Roussel

Elbez

, et al. Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. Eur Heart J 2015; 36: 2716–2728.

Sawada N, Nakanishi K, Daimon M, et al. Influence of visceral adiposity accumulation on adverse left and right ventricular mechanics in the community. Eur J Prev Cardiol. 2020; 27: 2006–2015.

10.

Mohammadi H, Ohm J, Discacciati A, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol 2020; 27: 1944–1952.